{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T16:31:51Z","timestamp":1793205111711,"version":"4.5.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"publisher","award":["BRC-1215-20005"],"award-info":[{"award-number":["BRC-1215-20005"]}],"id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"publisher","award":["MR\/L023784\/2"],"award-info":[{"award-number":["MR\/L023784\/2"]}],"id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Research Council","award":["MC-PC-17215"],"award-info":[{"award-number":["MC-PC-17215"]}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/N026977\/1"],"award-info":[{"award-number":["EP\/N026977\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["RP-2017-08-ST2-006"],"award-info":[{"award-number":["RP-2017-08-ST2-006"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Donepezil, galantamine, rivastigmine and memantine are potentially effective interventions for cognitive impairment in dementia, but the use of these drugs has not been personalised to individual patients yet. We examined whether artificial intelligence-based recommendations can identify the best treatment using routinely collected patient-level information.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Six thousand eight hundred four patients aged 59\u2013102\u2009years with a diagnosis of dementia from two National Health Service (NHS) Foundation Trusts in the UK were used for model training\/internal validation and external validation, respectively. A personalised prescription model based on the Recurrent Neural Network machine learning architecture was developed to predict the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) scores post-drug initiation. The drug that resulted in the smallest decline in cognitive scores between prescription and the next visit was selected as the treatment of choice. Change of cognitive scores up to 2 years after treatment initiation was compared for model evaluation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall, 1343 patients with MMSE scores were identified for internal validation and 285 [21.22%] took the drug recommended. After 2\u2009years, the reduction of mean [standard deviation] MMSE score in this group was significantly smaller than the remaining 1058 [78.78%] patients (0.60 [0.26] vs 2.80 [0.28];\n                      <jats:italic>P<\/jats:italic>\n                      = 0.02). In the external validation cohort (\n                      <jats:italic>N<\/jats:italic>\n                      = 1772), 222 [12.53%] patients took the drug recommended and reported a smaller MMSE reduction compared to the 1550 [87.47%] patients who did not (1.01 [0.49] vs 4.23 [0.60];\n                      <jats:italic>P<\/jats:italic>\n                      = 0.01). A similar performance gap was seen when testing the model on patients prescribed with AChEIs only.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>It was possible to identify the most effective drug for the real-world treatment of cognitive impairment in dementia at an individual patient level. Routine care patients whose prescribed medications were the best fit according to the model had better cognitive performance after 2 years.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-022-02250-2","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T22:04:38Z","timestamp":1643666678000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Personalised treatment for cognitive impairment in dementia: development and validation of an artificial intelligence model"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7531-4459","authenticated-orcid":false,"given":"Qiang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nemanja","family":"Vaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Koychev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Kormilitzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenpeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejo","family":"Nevado-Holgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,1]]},"reference":[{"issue":"10248","key":"2250_CR1","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413\u201346. https:\/\/doi.org\/10.1016\/S0140-6736(20)30367-6.","journal-title":"Lancet."},{"key":"2250_CR2","unstructured":"Dementia - World Health Organization 2 September 2021 [cited 2021 31 October]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia."},{"issue":"1","key":"2250_CR3","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3233\/ADR-210307","volume":"5","author":"I Yunusa","year":"2021","unstructured":"Yunusa I, Alsahali S, Ranes A, Eguale T. Comparative value of cholinesterase inhibitors and memantine in persons with moderate-to-severe Alzheimer\u2019s disease in the United States: a cost-effectiveness analysis. J Alzheimers Dis Rep. 2021;5(1):705\u201313. https:\/\/doi.org\/10.3233\/ADR-210307.","journal-title":"J Alzheimers Dis Rep."},{"issue":"1","key":"2250_CR4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1176\/appi.focus.15106","volume":"15","author":"PV Rabins","year":"2017","unstructured":"Rabins PV, Rovner BW, Rummans T, Schneider LS, Tariot PN. Guideline watch (October 2014): practice guideline for the treatment of patients with Alzheimer\u2019s disease and other dementias. Focus (Am Psychiatr Publ). 2017;15(1):110\u201328. https:\/\/doi.org\/10.1176\/appi.focus.15106.","journal-title":"Focus (Am Psychiatr Publ)."},{"key":"2250_CR5","doi-asserted-by":"publisher","first-page":"k2438","DOI":"10.1136\/bmj.k2438","volume":"361","author":"J Pink","year":"2018","unstructured":"Pink J, O\u2019Brien J, Robinson L, Longson D. Dementia: assessment, management and support: summary of updated NICE guidance. BMJ. 2018;361:k2438. https:\/\/doi.org\/10.1136\/bmj.k2438.","journal-title":"BMJ."},{"issue":"5","key":"2250_CR6","first-page":"433","volume":"60","author":"A Moore","year":"2014","unstructured":"Moore A, Patterson C, Lee L, Vedel I, Bergman H. Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia: recommendations for family physicians. Can Fam Physician. 2014;60(5):433\u20138.","journal-title":"Can Fam Physician."},{"issue":"5","key":"2250_CR7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1192\/bjp.2020.136","volume":"218","author":"N Vaci","year":"2021","unstructured":"Vaci N, Koychev I, Kim C-H, Kormilitzin A, Liu Q, Lucas C, et al. Real-world effectiveness, its predictors and onset of action of cholinesterase inhibitors and memantine in dementia: retrospective health record study. Br J Psychiatry. 2021;218(5):261\u20137. https:\/\/doi.org\/10.1192\/bjp.2020.136.","journal-title":"Br J Psychiatry."},{"issue":"1","key":"2250_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-021-00867-8","volume":"13","author":"M Seibert","year":"2021","unstructured":"Seibert M, M\u00fchlbauer V, Holbrook J, Voigt-Radloff S, Brefka S, Dallmeier D, et al. Efficacy and safety of pharmacotherapy for Alzheimer\u2019s disease and for behavioural and psychological symptoms of dementia in older patients with moderate and severe functional impairments: a systematic review of controlled trials. Alzheimers Res Ther. 2021;13(1):1\u201320. https:\/\/doi.org\/10.1186\/s13195-021-00867-8.","journal-title":"Alzheimers Res Ther."},{"issue":"1","key":"2250_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-020-01841-1","volume":"18","author":"K Wong-Lin","year":"2020","unstructured":"Wong-Lin K, McClean PL, McCombe N, Kaur D, Sanchez-Bornot JM, Gillespie P, et al. Shaping a data-driven era in dementia care pathway through computational neurology approaches. BMC Med. 2020;18(1):1\u201310. https:\/\/doi.org\/10.1186\/s12916-020-01841-1.","journal-title":"BMC Med."},{"key":"2250_CR10","doi-asserted-by":"publisher","unstructured":"Miah Y, Prima CNE, Seema SJ, Mahmud M, Kaiser MS. Performance comparison of machine learning techniques in identifying dementia from open access clinical datasets. Adv Smart Soft Comput Springer. 2021:79\u201389. https:\/\/doi.org\/10.1007\/978-981-15-6048-4_8.","DOI":"10.1007\/978-981-15-6048-4_8"},{"issue":"S5","key":"2250_CR11","doi-asserted-by":"publisher","first-page":"e045605","DOI":"10.1002\/alz.045605","volume":"16","author":"F Sepehrband","year":"2020","unstructured":"Sepehrband F, Barisano G, Sheikh-Bahaei N, Choupan J, Cabeen RP, Crawford MS, et al. Alteration of perivascular spaces in early cognitive decline: neuroimaging\/optimal neuroimaging measures for early detection. Alzheimers Dement. 2020;16(S5):e045605. https:\/\/doi.org\/10.1002\/alz.045605.","journal-title":"Alzheimers Dement."},{"key":"2250_CR12","doi-asserted-by":"publisher","first-page":"108544","DOI":"10.1016\/j.jneumeth.2019.108544","volume":"333","author":"P Forouzannezhad","year":"2020","unstructured":"Forouzannezhad P, Abbaspour A, Li C, Fang C, Williams U, Cabrerizo M, et al. A Gaussian-based model for early detection of mild cognitive impairment using multimodal neuroimaging. J Neurosci Methods. 2020;333:108544. https:\/\/doi.org\/10.1016\/j.jneumeth.2019.108544.","journal-title":"J Neurosci Methods."},{"issue":"S2","key":"2250_CR13","doi-asserted-by":"publisher","first-page":"e042558","DOI":"10.1002\/alz.042558","volume":"16","author":"O Erdo\u011fan","year":"2020","unstructured":"Erdo\u011fan O, Esme M, Balci C, Rafatov S, Cankurtaran M, Yavuz BB, et al. Identification of genomic biomarkers with machine learning for early and differential diagnosis of late-onset Alzheimer\u2019s disease (LOAD). Alzheimers Dement. 2020;16(S2):e042558. https:\/\/doi.org\/10.1002\/alz.042558.","journal-title":"Alzheimers Dement."},{"issue":"668","key":"2250_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3399\/bjgp18X695213","volume":"68","author":"VH Buch","year":"2018","unstructured":"Buch VH, Ahmed I, Maruthappu M. Artificial intelligence in medicine: current trends and future possibilities. Br J Gen Pract. 2018;68(668):143\u20134. https:\/\/doi.org\/10.3399\/bjgp18X695213.","journal-title":"Br J Gen Pract."},{"issue":"3","key":"2250_CR15","doi-asserted-by":"publisher","first-page":"ooab052","DOI":"10.1093\/jamiaopen\/ooab052","volume":"4","author":"S Kumar","year":"2021","unstructured":"Kumar S, Oh I, Schindler S, Lai AM, Payne PR, Gupta A. Machine learning for modeling the progression of Alzheimer disease dementia using clinical data: a systematic literature review. JAMIA Open. 2021;4(3):ooab052.","journal-title":"JAMIA Open"},{"key":"2250_CR16","doi-asserted-by":"crossref","unstructured":"Amini S, Zhang L, Hao B, Gupta A, Song M, Karjadi C, et al. An artificial intelligence-assisted method for dementia detection using images from the clock drawing test. J Alzheimers Dis. 2021;(Preprint):1\u20139.","DOI":"10.1101\/2021.03.06.21253047"},{"key":"2250_CR17","doi-asserted-by":"crossref","unstructured":"Zhang Z, Jiang Y, Cao X, Yang X, Zhu C, Li Y, et al. Deep learning based gait analysis for contactless dementia detection system from video camera. IEEE Int Symp Circuits Syst Proc. 2021; IEEE.","DOI":"10.1109\/ISCAS51556.2021.9401596"},{"key":"2250_CR18","doi-asserted-by":"publisher","unstructured":"Mahajan P, Baths V. Acoustic and language based deep learning approaches for Alzheimer's dementia detection from spontaneous speech. Front Aging Neurosci. 2021;13. https:\/\/doi.org\/10.3389\/fnagi.2021.623607.","DOI":"10.3389\/fnagi.2021.623607"},{"key":"2250_CR19","doi-asserted-by":"crossref","unstructured":"Ozdemir D, Cibulka J, Stepankova O, Holmerova I. Design and implementation framework of social assistive robotics for people with dementia-a scoping review. Health Technol (Berl). 2021:1\u201312.","DOI":"10.1007\/s12553-021-00522-0"},{"issue":"S11","key":"2250_CR20","doi-asserted-by":"publisher","first-page":"e037855","DOI":"10.1002\/alz.037855","volume":"16","author":"AA Khan","year":"2020","unstructured":"Khan AA. Robotics in dementia: caregiving needs addressed by an assistive robot in combination with wearable sensors. Alzheimers Dement. 2020;16(S11):e037855. https:\/\/doi.org\/10.1002\/alz.037855.","journal-title":"Alzheimers Dement."},{"issue":"3","key":"2250_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000497800","volume":"47","author":"AJ Astell","year":"2019","unstructured":"Astell AJ, Bouranis N, Hoey J, Lindauer A, Mihailidis A, Nugent C, et al. Technology and dementia: the future is now. Dement Geriatr Cogn Disord. 2019;47(3):131\u20139. https:\/\/doi.org\/10.1159\/000497800.","journal-title":"Dement Geriatr Cogn Disord."},{"key":"2250_CR22","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3389\/fphys.2019.00672","volume":"10","author":"P M\u00fcllers","year":"2019","unstructured":"M\u00fcllers P, Taubert M, M\u00fcller NG. Physical exercise as personalized medicine for dementia prevention? Front Physiol. 2019;10:672. https:\/\/doi.org\/10.3389\/fphys.2019.00672.","journal-title":"Front Physiol."},{"key":"2250_CR23","doi-asserted-by":"publisher","unstructured":"Evans SC, Garabedian C, Bray J. \u2018Now he sings\u2019. The My Musical Memories Reminiscence programme: personalised interactive reminiscence sessions for people living with dementia. Dementia (London). 2019;18(3):1181-1198, https:\/\/doi.org\/10.1177\/1471301217710531.","DOI":"10.1177\/1471301217710531"},{"key":"2250_CR24","doi-asserted-by":"crossref","unstructured":"Denis M. U.K. clinical record interactive search (CRIS). Alzheimers Dement. 2017;13(7).","DOI":"10.1016\/j.jalz.2017.07.413"},{"issue":"3","key":"2250_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201cMini-mental state\u201d: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189\u201398. https:\/\/doi.org\/10.1016\/0022-3956(75)90026-6.","journal-title":"J Psychiatr Res."},{"issue":"4","key":"2250_CR26","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695\u20139. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53221.x.","journal-title":"J Am Geriatr Soc."},{"key":"2250_CR27","doi-asserted-by":"publisher","first-page":"103429","DOI":"10.1016\/j.jbi.2020.103429","volume":"107","author":"S Goodday","year":"2020","unstructured":"Goodday S, Kormilitzin A, Vaci N, Liu Q, Cipriani A, Smith T, et al. Maximizing the use of social and behavioural information from secondary care mental health electronic health records. J Biomed Inform. 2020;107:103429. https:\/\/doi.org\/10.1016\/j.jbi.2020.103429.","journal-title":"J Biomed Inform."},{"key":"2250_CR28","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3389\/fpsyt.2020.00268","volume":"11","author":"M Senior","year":"2020","unstructured":"Senior M, Burghart M, Yu R, Kormilitzin A, Liu Q, Vaci N, et al. Identifying predictors of suicide in severe mental illness: a feasibility study of a clinical prediction rule (Oxford Mental Illness and Suicide Tool or OxMIS). Front Psychiatry. 2020;11:268. https:\/\/doi.org\/10.3389\/fpsyt.2020.00268.","journal-title":"Front Psychiatry."},{"issue":"1","key":"2250_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1136\/ebmental-2019-300134","volume":"23","author":"N Vaci","year":"2020","unstructured":"Vaci N, Liu Q, Kormilitzin A, De Crescenzo F, Kurtulmus A, Harvey J, et al. Natural language processing for structuring clinical text data on depression using UK-CRIS. Evid Based Ment Health. 2020;23(1):21\u20136. https:\/\/doi.org\/10.1136\/ebmental-2019-300134.","journal-title":"Evid Based Ment Health."},{"issue":"2","key":"2250_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192360","volume":"13","author":"S Gehrmann","year":"2018","unstructured":"Gehrmann S, Dernoncourt F, Li Y, Carlson ET, Wu JT, Welt J, et al. Comparing deep learning and concept extraction based methods for patient phenotyping from clinical narratives. PloS ONE. 2018;13(2):e0192360. https:\/\/doi.org\/10.1371\/journal.pone.0192360.","journal-title":"PloS ONE."},{"issue":"22","key":"2250_CR31","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1056\/NEJMoa0806142","volume":"360","author":"GM Savva","year":"2009","unstructured":"Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, Brayne C. Age, neuropathology, and dementia. N Engl J Med. 2009;360(22):2302\u20139. https:\/\/doi.org\/10.1056\/NEJMoa0806142.","journal-title":"N Engl J Med."},{"issue":"7","key":"2250_CR32","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s40520-020-01697-8","volume":"33","author":"G Zuliani","year":"2021","unstructured":"Zuliani G, Polastri M, Romagnoli T, Marabini L, Seripa D, Cervellati C, et al. Clinical and demographic parameters predict the progression from mild cognitive impairment to dementia in elderly patients. Aging Clin Exp Res. 2021;33(7):1895\u2013902. https:\/\/doi.org\/10.1007\/s40520-020-01697-8.","journal-title":"Aging Clin Exp Res."},{"issue":"11","key":"2250_CR33","doi-asserted-by":"publisher","first-page":"e109484","DOI":"10.1371\/journal.pone.0109484","volume":"9","author":"G Perera","year":"2014","unstructured":"Perera G, Khondoker M, Broadbent M, Breen G, Stewart R. Factors associated with response to acetylcholinesterase inhibition in dementia: a cohort study from a secondary mental health care case register in London. PloS One. 2014;9(11):e109484. https:\/\/doi.org\/10.1371\/journal.pone.0109484.","journal-title":"PloS One."},{"issue":"4","key":"2250_CR34","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0197-4580(01)00231-7","volume":"22","author":"A Ruitenberg","year":"2001","unstructured":"Ruitenberg A, Ott A, van Swieten JC, Hofman A, Breteler MM. Incidence of dementia: does gender make a difference? Neurobiol Aging. 2001;22(4):575\u201380. https:\/\/doi.org\/10.1016\/S0197-4580(01)00231-7.","journal-title":"Neurobiol Aging."},{"issue":"1","key":"2250_CR35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/gps.2484","volume":"26","author":"N Mukadam","year":"2011","unstructured":"Mukadam N, Cooper C, Livingston G. A systematic review of ethnicity and pathways to care in dementia. Int J Geriatr Psychiatry. 2011;26(1):12\u201320. https:\/\/doi.org\/10.1002\/gps.2484.","journal-title":"Int J Geriatr Psychiatry."},{"issue":"1","key":"2250_CR36","doi-asserted-by":"publisher","first-page":"e008565","DOI":"10.1136\/bmjopen-2015-008565","volume":"6","author":"A Sundstr\u00f6m","year":"2016","unstructured":"Sundstr\u00f6m A, Westerlund O, Kotyrlo E. Marital status and risk of dementia: a nationwide population-based prospective study from Sweden. BMJ Open. 2016;6(1):e008565.","journal-title":"BMJ Open"},{"key":"2250_CR37","doi-asserted-by":"publisher","first-page":"113808","DOI":"10.1016\/j.socscimed.2021.113808","volume":"275","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Liu H. Choi S-wE. Marital loss and risk of dementia: do race and gender matter. Soc Sci Med. 2021;275:113808.","journal-title":"Soc Sci Med"},{"issue":"11","key":"2250_CR38","first-page":"14","volume":"35","author":"MM Mielke","year":"2018","unstructured":"Mielke MM. Sex and gender differences in Alzheimer\u2019s disease dementia. Psychiatr Times. 2018;35(11):14.","journal-title":"Psychiatr Times."},{"issue":"4","key":"2250_CR39","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/13607863.2016.1277976","volume":"22","author":"Z Zhou","year":"2018","unstructured":"Zhou Z, Wang P, Fang Y. Loneliness and the risk of dementia among older Chinese adults: gender differences. Aging Ment Health. 2018;22(4):519\u201325. https:\/\/doi.org\/10.1080\/13607863.2016.1277976.","journal-title":"Aging Ment Health."},{"key":"2250_CR40","doi-asserted-by":"publisher","unstructured":"Arevalo-Rodriguez I, Smailagic N, i Figuls MR, Ciapponi A, Sanchez-Perez E, Giannakou A, et al. Mini-Mental State Examination (MMSE) for the detection of Alzheimer\u2019s disease and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2015;3. https:\/\/doi.org\/10.1002\/14651858.CD010783.pub2.","DOI":"10.1002\/14651858.CD010783.pub2"},{"key":"2250_CR41","doi-asserted-by":"crossref","unstructured":"Davis DH, Creavin ST, Yip JL, Noel-Storr AH, Brayne C, Cullum S. Montreal Cognitive Assessment for the detection of dementia. Cochrane Database Syst Rev. 2021;7(7).","DOI":"10.1002\/14651858.CD010775.pub3"},{"issue":"1","key":"2250_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2296-9-29","volume":"9","author":"P Pezzotti","year":"2008","unstructured":"Pezzotti P, Scalmana S, Mastromattei A, Di Lallo D. The accuracy of the MMSE in detecting cognitive impairment when administered by general practitioners: a prospective observational study. BMC Fam Pract. 2008;9(1):1\u201311. https:\/\/doi.org\/10.1186\/1471-2296-9-29.","journal-title":"BMC Fam Pract."},{"issue":"5","key":"2250_CR43","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.jalz.2012.10.001","volume":"9","author":"DR Roalf","year":"2013","unstructured":"Roalf DR, Moberg PJ, Xie SX, Wolk DA, Moelter ST, Arnold SE. Comparative accuracies of two common screening instruments for classification of Alzheimer\u2019s disease, mild cognitive impairment, and healthy aging. Alzheimers Dement. 2013;9(5):529\u201337. https:\/\/doi.org\/10.1016\/j.jalz.2012.10.001.","journal-title":"Alzheimers Dement."},{"issue":"6","key":"2250_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12859-021-04224-2","volume":"22","author":"S Kumar","year":"2021","unstructured":"Kumar S, Sharma R, Tsunoda T, Kumarevel T, Sharma A. Forecasting the spread of COVID-19 using LSTM network. BMC Bioinforma. 2021;22(6):1\u20139. https:\/\/doi.org\/10.1186\/s12859-021-04224-2.","journal-title":"BMC Bioinforma"},{"key":"2250_CR45","doi-asserted-by":"publisher","first-page":"18076","DOI":"10.1109\/ACCESS.2019.2896988","volume":"7","author":"Q Liu","year":"2019","unstructured":"Liu Q, Li R, Hu H, Gu D. Using unsupervised deep learning technique for monocular visual odometry. IEEE Access. 2019;7:18076\u201388. https:\/\/doi.org\/10.1109\/ACCESS.2019.2896988.","journal-title":"IEEE Access."},{"issue":"1","key":"2250_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12911-020-01345-1","volume":"21","author":"A Guo","year":"2021","unstructured":"Guo A, Beheshti R, Khan YM, Langabeer JR, Foraker RE. Predicting cardiovascular health trajectories in time-series electronic health records with LSTM models. BMC Med Inform Decis Mak. 2021;21(1):1\u201310. https:\/\/doi.org\/10.1186\/s12911-020-01345-1.","journal-title":"BMC Med Inform Decis Mak."},{"issue":"1","key":"2250_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-36745-x","volume":"9","author":"J Zhao","year":"2019","unstructured":"Zhao J, Feng Q, Wu P, Lupu RA, Wilke RA, Wells QS, et al. Learning from longitudinal data in electronic health record and genetic data to improve cardiovascular event prediction. Sci Rep. 2019;9(1):1\u201310. https:\/\/doi.org\/10.1038\/s41598-018-36745-x.","journal-title":"Sci Rep."},{"issue":"8","key":"2250_CR48","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/gps.1557","volume":"21","author":"RVD Putt","year":"2006","unstructured":"Putt RVD, Dineen C, Janes D, Series H, McShane R. Effectiveness of acetylcholinesterase inhibitors: diagnosis and severity as predictors of response in routine practice. Int J Geriatr Psychiatry. 2006;21(8):755\u201360. https:\/\/doi.org\/10.1002\/gps.1557.","journal-title":"Int J Geriatr Psychiatry."},{"issue":"1","key":"2250_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2377-12-134","volume":"12","author":"C Wattmo","year":"2012","unstructured":"Wattmo C, Wallin \u00c5K, Minthon L. Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer\u2019s disease cohort. BMC Neurol. 2012;12(1):1\u201310. https:\/\/doi.org\/10.1186\/1471-2377-12-134.","journal-title":"BMC Neurol."},{"issue":"1","key":"2250_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41597-019-0103-9","volume":"6","author":"H Harutyunyan","year":"2019","unstructured":"Harutyunyan H, Khachatrian H, Kale DC, Ver Steeg G, Galstyan A. Multitask learning and benchmarking with clinical time series data. Sci Data. 2019;6(1):1\u201318. https:\/\/doi.org\/10.1038\/s41597-019-0103-9.","journal-title":"Sci Data."},{"issue":"10","key":"2250_CR51","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1093\/bioinformatics\/btq134","volume":"26","author":"A Altmann","year":"2010","unstructured":"Altmann A, Tolo\u015fi L, Sander O, Lengauer T. Permutation importance: a corrected feature importance measure. Bioinformatics. 2010;26(10):1340\u20137. https:\/\/doi.org\/10.1093\/bioinformatics\/btq134.","journal-title":"Bioinformatics."},{"key":"2250_CR52","doi-asserted-by":"publisher","unstructured":"Ramachandran KM, Tsokos CP. Mathematical statistics with applications in R\u00a03rd Edition: Academic Press; 2020.\u00a0https:\/\/doi.org\/10.1016\/C2018-0-02285-9.","DOI":"10.1016\/C2018-0-02285-9"},{"key":"2250_CR53","unstructured":"Abadi M, Agarwal A, Barham P, Brevdo E, Chen Z, Citro C, et al. TensorFlow: large-scale machine learning on heterogeneous distributed systems. arXiv preprint arXiv. 2016:160304467."},{"key":"2250_CR54","unstructured":"Chollet F. Deep learning with Python: Simon and Schuster; 2021.\u00a0https:\/\/www.manning.com\/books\/deep-learning-with-python-second-edition"},{"key":"2250_CR55","doi-asserted-by":"publisher","unstructured":"McShane R, Westby MJ, Roberts E, Minakaran N, Schneider L, Farrimond LE, et al. Memantine for dementia. Cochrane Database Syst Rev. 2019;3. https:\/\/doi.org\/10.1002\/14651858.CD003154.pub6.","DOI":"10.1002\/14651858.CD003154.pub6"},{"issue":"11","key":"2250_CR56","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.2165\/00003495-200666110-00015","volume":"66","author":"DM Robinson","year":"2006","unstructured":"Robinson DM, Keating GM. Memantine: a review of its use in Alzheimer\u2019s disease. Drugs. 2006;66(11):1515\u201334. https:\/\/doi.org\/10.2165\/00003495-200666110-00015.","journal-title":"Drugs."},{"issue":"27","key":"2250_CR57","doi-asserted-by":"publisher","first-page":"e16091","DOI":"10.1097\/MD.0000000000016091","volume":"98","author":"C-C Cui","year":"2019","unstructured":"Cui C-C, Sun Y, Wang X-Y, Zhang Y, Xing Y. The effect of anti-dementia drugs on Alzheimer disease-induced cognitive impairment: a network meta-analysis. Medicine (Baltimore). 2019;98(27):e16091.","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"2250_CR58","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/gps.1133","volume":"19","author":"A Whitehead","year":"2004","unstructured":"Whitehead A, Perdomo C, Pratt RD, Birks J, Wilcock GK, Evans JG. Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer\u2019s disease: a meta-analysis of individual patient data from randomised controlled trials. Int J Geriatr Psychiatry. 2004;19(7):624\u201333. https:\/\/doi.org\/10.1002\/gps.1133.","journal-title":"Int J Geriatr Psychiatry."},{"issue":"3-4","key":"2250_CR59","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000486546","volume":"45","author":"R Knight","year":"2018","unstructured":"Knight R, Khondoker M, Magill N, Stewart R, Landau S. A systematic review and meta-analysis of the effectiveness of acetylcholinesterase inhibitors and memantine in treating the cognitive symptoms of dementia. Dement Geriatr Cogn Disord. 2018;45(3-4):131\u201351. https:\/\/doi.org\/10.1159\/000486546.","journal-title":"Dement Geriatr Cogn Disord."},{"issue":"1","key":"2250_CR60","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1684\/pnv.2020.0843","volume":"18","author":"C Hazif-Thomas","year":"2020","unstructured":"Hazif-Thomas C. Lefebvre des No\u00ebttes V. Issues of the delisting of anti-Alzheimer\u2019s drugs in France: between the law and ethics. Geriatr Psychol Neuropsychiatr Vieil. 2020;18(1):97\u2013102. https:\/\/doi.org\/10.1684\/pnv.2020.0843.","journal-title":"Geriatr Psychol Neuropsychiatr Vieil."},{"issue":"4","key":"2250_CR61","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00702-016-1517-6","volume":"123","author":"R Biundo","year":"2016","unstructured":"Biundo R, Weis L, Bostantjopoulou S, Stefanova E, Falup-Pecurariu C, Kramberger M, et al. MMSE and MoCA in Parkinson\u2019s disease and dementia with Lewy bodies: a multicenter 1-year follow-up study. J Neural Transm. 2016;123(4):431\u20138. https:\/\/doi.org\/10.1007\/s00702-016-1517-6.","journal-title":"J Neural Transm."},{"issue":"11","key":"2250_CR62","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1212\/WNL.55.11.1609","volume":"55","author":"C Dufouil","year":"2000","unstructured":"Dufouil C, Clayton D, Brayne C, Chi L-Y, Dening TR, Paykel E, et al. Population norms for the MMSE in the very old: estimates based on longitudinal data. Neurology. 2000;55(11):1609\u201313. https:\/\/doi.org\/10.1212\/WNL.55.11.1609.","journal-title":"Neurology."},{"issue":"2","key":"2250_CR63","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/gps.5420","volume":"36","author":"G Perera","year":"2021","unstructured":"Perera G, Mueller C, Stewart R. Factors associated with slow progression of cognitive impairment following first dementia diagnosis. Int J Geriatr Psychiatry. 2021;36(2):271\u201385. https:\/\/doi.org\/10.1002\/gps.5420.","journal-title":"Int J Geriatr Psychiatry."},{"key":"2250_CR64","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.neurobiolaging.2020.12.005","volume":"99","author":"J Bae","year":"2021","unstructured":"Bae J, Stocks J, Heywood A, Jung Y, Jenkins L, Hill V, et al. Transfer learning for predicting conversion from mild cognitive impairment to dementia of Alzheimer\u2019s type based on a three-dimensional convolutional neural network. Neurobiol Aging. 2021;99:53\u201364. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.12.005.","journal-title":"Neurobiol Aging."},{"issue":"3","key":"2250_CR65","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1136\/ebmental-2020-300149","volume":"23","author":"F De Crescenzo","year":"2020","unstructured":"De Crescenzo F, Garriga C, Tomlinson A, Coupland C, Efthimiou O, Fazel S, et al. Real-world effect of antidepressants for depressive disorder in primary care: protocol of a population-based cohort study. Evid Based Ment Health. 2020;23(3):122\u20136. https:\/\/doi.org\/10.1136\/ebmental-2020-300149.","journal-title":"Evid Based Ment Health."},{"issue":"3","key":"2250_CR66","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ejpsy.2017.06.003","volume":"31","author":"R Mateos-\u00c1lvarez","year":"2017","unstructured":"Mateos-\u00c1lvarez R, Ramos-R\u00edos R, L\u00f3pez-Mor\u00ed\u00f1igo J. Comparative analysis between the MMSE and the RUDAS for dementia screening in low educated people in a Spanish psychogeriatric clinic. Eur J Psychiatry. 2017;31(3):119\u201326. https:\/\/doi.org\/10.1016\/j.ejpsy.2017.06.003.","journal-title":"Eur J Psychiatry."},{"key":"2250_CR67","doi-asserted-by":"publisher","unstructured":"Mitchell AJ. The Mini-Mental State Examination (MMSE): update on its diagnostic accuracy and clinical utility for cognitive disorders. Cogn Screen Instrum: Springer. 2017:37\u201348. https:\/\/doi.org\/10.1007\/978-3-319-44775-9_3.","DOI":"10.1007\/978-3-319-44775-9_3"},{"key":"2250_CR68","doi-asserted-by":"publisher","unstructured":"Arevalo-Rodriguez I, Smailagic N, Roqu\u00e9-Figuls M, Ciapponi A, Sanchez-Perez E, Giannakou A, et al. Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2021;7(7). https:\/\/doi.org\/10.1002\/14651858.CD010783.pub3.","DOI":"10.1002\/14651858.CD010783.pub3"},{"issue":"4","key":"2250_CR69","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s13760-018-1036-3","volume":"118","author":"D Piersma","year":"2018","unstructured":"Piersma D, Fuermaier A, de Waard D, De Deyn P, Davidse R, De Groot J, et al. The MMSE should not be the sole indicator of fitness to drive in mild Alzheimer\u2019s dementia. Acta Neurol Belg. 2018;118(4):637\u201342. https:\/\/doi.org\/10.1007\/s13760-018-1036-3.","journal-title":"Acta Neurol Belg."},{"issue":"2","key":"2250_CR70","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/0269881116680924","volume":"31","author":"JT O\u2019Brien","year":"2017","unstructured":"O\u2019Brien JT, Holmes C, Jones M, Jones R, Livingston G, McKeith I, et al. Clinical practice with anti-dementia drugs: a revised (third) consensus statement from the British Association for Psychopharmacology. J Psychopharmacol. 2017;31(2):147\u201368. https:\/\/doi.org\/10.1177\/0269881116680924.","journal-title":"J Psychopharmacol."},{"issue":"2","key":"2250_CR71","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/ebmental-2020-300184","volume":"24","author":"SZ Levine","year":"2021","unstructured":"Levine SZ, Yoshida K, Goldberg Y, Samara M, Cipriani A, Efthimiou O, et al. Linking the Mini-Mental State Examination, the Alzheimer\u2019s Disease Assessment Scale\u2013Cognitive Subscale and the Severe Impairment Battery: evidence from individual participant data from five randomised clinical trials of donepezil. Evid Based Ment Health. 2021;24(2):56\u201361. https:\/\/doi.org\/10.1136\/ebmental-2020-300184.","journal-title":"Evid Based Ment Health."}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02250-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-022-02250-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02250-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T22:06:52Z","timestamp":1643666812000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-022-02250-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2250"],"URL":"https:\/\/doi.org\/10.1186\/s12916-022-02250-2","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,1]]},"assertion":[{"value":"11 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. All procedures involving human subjects\/patients were approved by the local CRIS oversight committee and are covered by approval for the CRIS database granted by the Oxfordshire and Southern Health Research Ethics Committee. Individual patient consent is not required for this use of anonymised, routine data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Individual patient consent is not required for this use of anonymised, routine data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Ivan Koychev is a paid medical advisor for Cognetivity, Mantrah and Sharp Therapeutics companies which specialise in developing digital solutions for monitoring cognition or supporting independence in patients. Andrea Cipriani has received research and consultancy fees from INCiPiT (Italian Network for Paediatric Trials), CARIPLO Foundation and Angelini Pharma, outside the submitted work. Alejo Nevado-Holgado works as a consultant in Akrivia Health (\n                      \n                      ) and has obtained funding from Johnson & Johnson, Ono Pharma and GSK. None of those funds is involved in this publication. The other authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45"}}